Ophthalmic Industry Innovation and Development Forum at VBEF 2026: Accelerating Domestic Substitution and Global Expansion
As a golden sector within the healthcare industry, ophthalmology has consistently attracted significant attention.
On the policy front, the introduction of multiple favorable policies has significantly promoted the market-oriented development of the ophthalmic industry;
On the investment front, even as the primary healthcare market generally cooled down, investment in the ophthalmology industry remained highly active, ranking among the top sectors for financing and investment across all healthcare subsectors in 2024;
From the perspective of corporate development, multiple ophthalmology sub-sectors have achieved breakthrough progress in recent years. For instance, the high-end ophthalmic imaging and surgical equipment sectors have seen the emergence of numerous innovative products labeled as “global firsts” or “China’s first,” injecting robust domestic strength into ophthalmic diagnosis and treatment. Intraocular lenses (IOLs) have also taken the lead in breaking import monopolies, with their commercialization accelerating continuously. While cost-effective products are capturing market share, innovative offerings continue to emerge in abundance.
As for the ophthalmic medical services market, in response to the impact of centralized procurement and periodic weakness in consumer spending, ophthalmic service providers have also adjusted their development strategies. Some are actively restructuring their business portfolios to identify new growth drivers for revenue, while others are refining their market expansion strategies to pursue intensive cultivation of regional markets.
Meanwhile, as a newly emerging hotspot in the ophthalmology industry in recent years, the optometry sector has seen a continuous influx of domestic players. Some have entered the market as chain medical service providers, offering full-lifecycle eye health management services, while others have established themselves as myopia prevention and control platforms, leveraging digital technologies and artificial intelligence to facilitate the efficient implementation of myopia prevention and control measures.
All these developments have not only driven innovation in China’s ophthalmology industry but also attracted the attention of capital markets, thereby reinvesting in and further fueling industrial growth. Throughout this process, change is constant, with opportunities lying deep within the industry.Based on this,VCBeat to Host "Innovation and Development in the Ophthalmology Industry" Forum at the VBEF Top 100 Future Healthcare and Pharma Expo on May 9–10, inviting clinical experts from the ophthalmology sector, research institutions, upstream and downstream enterprises, seasoned investors, and channel partners to jointly discuss independent innovation and global development of China’s ophthalmology industry, while strengthening academic exchange and industrial collaboration within the field.
Focusing on the practical pathways to break the import monopoly in the fields of ophthalmic equipment and consumables, this report quantifies industrial progress through in-depth industry research, and reveals the logic behind the acceleration of domestic substitution by integrating policy trends, technological innovations, and clinical needs.
Showcasing interdisciplinary innovations such as AI-assisted diagnosis, integration of medicine and engineering, and precision optometry, this approach covers the entire value chain—from data-driven eye health management to intelligent prevention and control products—highlighting how “technological breakthroughs” support the operation of existing markets and the global expansion of high-end imaging equipment.
Exploring Competitive Strategies in China’s Saturated Market and Emerging Growth Opportunities, Analyzing the Global Expansion Experience of High-End Medical Imaging, and Ultimately Connecting the “Policy–R&D–Clinical–Commercial” Closed Loop Through Upstream and Downstream Supply Chain Roundtable Discussions to Construct an Innovation Ecosystem Map for the Ophthalmology Industry.
May 10, 14:00-17:00
(The following schedule is tentative and subject to on-site arrangements.)
14：00-15：00
“Prospects for the Trend of Domestic Ophthalmic Industry – Policy, Technology, Application” (tentative)
Clinical Expert
Report Release: "Research Report on the Localization Process of High-End Ophthalmic Equipment"
Jiao Yanli | Senior Researcher, VBInsight
“Market Recovery: Observations on Investment & BD Opportunities in the Ophthalmology Sector”
Investment Institutions
15：00-16：20
“Shifting Focus to the Existing Market: Expansion Strategies Adapt to the Trend”
Chain Ophthalmic Service Provider
"Targeting Overseas Markets: Practices and Experiences of Chinese High-End Imaging Equipment Going Global"
Wang Yingqi | CEO of TopEye Medical
“Breaking Import Monopolies: Accelerating Innovation in Domestically Produced Ophthalmic Consumables”
Representative of Domestic Ophthalmic Consumables Manufacturers
“AI + Precision Optometry: Disruptive Innovation from Data-Driven Diagnosis to Full-Lifecycle Eye Health Management”
Representatives of Optometry Equipment Companies
“Integration of Medicine and Engineering: Myopia Prevention and Control Enter the Era of Precision Intelligence”
Representative of Enterprises in the Myopia Prevention and Control Product Category
16：20-17：00
Roundtable Discussion: Innovation and Development Opportunities in the Ophthalmology Industry (Tentative)
Panelists: Representatives from upstream, midstream, and downstream enterprises in the ophthalmology industry chain, research institutions, and clinical practitioners
Event Agenda:
1. Repost this tweet to your WeChat Moments (set visibility to "Public," not restricted to specific groups);
2. The post must remain visible for 1 hour, and accumulate 18 likes on WeChat Moments;
3. Add the customer service WeChat account and send the screenshot;
4. Obtain a complimentary conference ticket valued at 399 yuan;
Event Agenda:
1. Your company belongs to the upstream or downstream enterprises in the field of ophthalmology;
2. Add the customer service WeChat account and provide your personal business card;
3. Receive a complimentary conference ticket valued at 399 yuan;
(Choose one of two promotional offers)
Scan the QR code below to join the promotional event for the “Ophthalmology Industry Innovation and Development Forum” and contact the organizing committee to obtain tickets!
